<?xml version="1.0" encoding="UTF-8"?>
<ref id="B100">
 <label>100.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>da Silva</surname>
    <given-names>VO</given-names>
   </name>
   <name>
    <surname>Borja-Cabrera</surname>
    <given-names>GP</given-names>
   </name>
   <name>
    <surname>Correia Pontes</surname>
    <given-names>NN</given-names>
   </name>
   <name>
    <surname>de Souza</surname>
    <given-names>EP</given-names>
   </name>
   <name>
    <surname>Luz</surname>
    <given-names>KG</given-names>
   </name>
   <name>
    <surname>Palatnik</surname>
    <given-names>M</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (São Gonçalo do Amaranto, RN)</article-title>. 
  <source>Vaccine</source>. (
  <year>2000</year>) 
  <volume>19</volume>:
  <fpage>1082</fpage>–
  <lpage>92</lpage>. 
  <pub-id pub-id-type="doi">10.1016/S0264-410X(00)00339-X</pub-id>
  <?supplied-pmid 11137242?>
  <pub-id pub-id-type="pmid">11137242</pub-id>
 </mixed-citation>
</ref>
